4.4 Article

Ultrasound imaging of liver metastases in the delayed parenchymal phase following administration of Sonazoid™ using a destructive mode technique (Agent Detection lmaging™)

Journal

CLINICAL RADIOLOGY
Volume 63, Issue 10, Pages 1112-1120

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.crad.2008.03.008

Keywords

-

Ask authors/readers for more resources

AIM: To determine whether delayed-phase liver imaging using a destructive imaging mode is able to provide similar information to phase-inversion imaging regarding detection and conspicuity of liver metastases. MATERIAL AND METHODS: Patients with a known primary malignancy with suspected liver metastases were recruited. Ultrasound was performed at baseline, and up to 5 min after the administration of Sonazoid (TM), using phase-inversion imaging at both tow and high mechanical indices (MI) and at 10-15 min using destructive imaging. One of four doses of Sonazoid (TM) was used: 0.008, 0.08, 0.12, and 0.36 mu l/kg of body weight. Two observers documented lesion number and conspicuity subjectively, and divided the patients into group A (no lesions), group B (one to seven lesions), and group C-I (III) (more than eight lesions, subdivided with increasing lesion number) depending on the number of lesions and categories I-IV based on lesion conspicuity. These parameters were compared with contrast-enhanced computed tomography (CECT) as the reference standard. RESULTS: Sixteen patients were examined (six women, 10 men), mean age 67.3 years (range 48-83 years). Based on CECT imaging, the division was as follows: group A n 1, group B n = 8, group C-I n 1, group C-II n - 4, group C-III n - 2. The accuracy of baseline ultrasound versus CECT was 75% (in 12 of the 16 patients the group concurred) and the accuracy for contrast-enhanced ultrasound (CEUS) versus CECT was 93.8% (15/16). There was a significant improvement in lesion conspicuity for both low (p - 0.0029) and high MI phase-inversion (p = 0.0004) and destructive (p - 0.0015) CEUS imaging in comparison with baseline ultrasound. Artefact was noted at higher doses of Sonazoid (TM); and no side effects were recorded. CONCLUSION: Following a single, intravenous injection of Sonazoid (TM), the properties of this microbubble allow for a and robust examination of the liver using two different techniques with comparable results. (C) 2008 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available